key: cord-1013954-32lypzjp authors: Wang, Zhufeng; Wang, Yingzhi; Yang, Zhaowei; Wu, Hongkai; Liang, Jingyi; Liang, Hanwen; Lin, Huimin; Chen, Ruchong; Ou, Younger; Wang, Fengyan; Wang, Yuan; Wang, Yan; Luo, Weizhan; Li, Naijian; Li, Zhengtu; Xie, Jiaxing; Jiang, Mei; Li, Shiyue title: The use of non-invasive ventilation in COVID-19: a systematic review date: 2021-03-30 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.03.078 sha: 772ba54f6ae3bbd36a746eecbc175d1119814476 doc_id: 1013954 cord_uid: 32lypzjp Objective Guidelines from different areas on the use of non-invasive ventilation in COVID-19 have generally been inconsistent. The goals were to appraise the quality and availability of guidelines stated and whether non-invasive ventilation in the early stage of the pandemic is of importance. Design and Method Databases including PubMed, Web of Science, Cochrane Library, and websites of international organizations and gray databases were searched up to June 23, 2020. We also hand-searched the reference lists of eligible papers. Results A total of 26 guidelines met the inclusion criteria. Regarding the appraisal by the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument, the guidelines’ methodological quality was low. Among six domains, Rigour. of Developmentand Editorial Independencewere of the lowest quality. Given the lack of evidence from randomized clinical trials and the great differences between different regions, non-invasive ventilation’s recommendations generated a considerable debate at the early stage of COVID-19. Conclusions Improving the methodological quality of the guidelines should be a goal in future pandemics. Additionally, more well-designed randomized clinical trials are needed to solve the controversy on the impact of non-invasive ventilation. The outbreak of COVID-19 began in Wuhan, China, in late December 2019, and it has since spread globally, leading to an ongoing pandemic. Among COVID-19 patients, the percentage of patients with severe and critical COVID-19 was reported to be 13.8% and 4.7%, respectively ( China CDC, 2020 ). The more likely cause of death is severe respiratory failure( Berlin DA, Gulick RM, Martinez FJ, 2020 ). Thus, if means of respiratory support, such as non-invasive ventilation (NIV), can be chosen correctly and implemented in time, the fatality in severe patients could be reduced ( Sundaram M et al., 2020 ). However, the guidelines from different areas for NIV use for patients with COVID-19 are inconsistent. During times of crisis, guidelines are vital for clinical practice. Evidence can be more reliable based on a well-designed guideline. The Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument is the "gold standard" for the guideline development appraisal to evaluate the guidelines' quality. Therefore, based on the appraisal according to the AGREE II instrument, we will discuss the issues that J o u r n a l P r e -p r o o f should be paid attention to developing guidelines during the pandemic, such as transparency in the development. More importantly, we will compare clinical recommendations from the aspects of safety issues (e.g., aerosol generation, ward selection), optimizing the interface, indications, modes, and parameter setting of NIV from each guideline. To our knowledge, this is the first review to combine the use of AGREE II instrument for guidelines development appraisal and critical assessment on the use of NIV during the COVID-19 pandemic. This effort will address the issues while developing a guideline, even in the context of a pandemic, and enhance the clinicians' understanding on the use of NIV when facing COVID-19. This study was registered with the PROSPERO international prospective register of systematic reviews (CRD42020198410), and the results were reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) J o u r n a l P r e -p r o o f statements (checklist) ( Liberati A et al., 2009 ). An additional Word file includes several details [see Additional file 1: eMethods 1]. Databases including PubMed, Web of Science, Cochrane Library, and international organizations' websites (e.g., World Health Organization and National Institutes of Health) and gray databases (e.g., Guidelines International Network and Scottish Intercollegiate Guidelines Network) were searched up to June 23, 2020. The search was limited to the English language. We also hand-searched the reference lists of eligible papers and contacted experts in the field to ensure a comprehensive review. An additional Word file lists in detail these procedures [see Additional file 1: eMethods 2 and eMethods 3]. We included documents that focused on the management of NIV for patients with COVID-19. The documents should be developed by international, national health J o u r n a l P r e -p r o o f organizations, or medical societies. If there were multiple versions of the document, only the latest version was included. Only documents in English were eligible. We excluded documents without a full-text version. Any paper introducing the epidemiology, nosocomial infection, quarantine, home care, prevention, clinical manifestations, or rehabilitation was excluded. Papers only focused on newborns, children, pregnant women, or the elderly, which could be judged from the title or abstract, were also excluded. Publication types such as systematic reviews, case reports, commentaries, letters, clinical trials, or handbooks were not eligible. With these criteria, one researcher screened the documents individually, and any uncertainty was resolved in discussion with another two researchers. The following information from each article was extracted using standardized data extracted form: title, issuing full society name, the acronym of the guideline, date of publication, country applied, region, target population, a type of guideline, a type of publication, development method, grading system, the strength of recommendations, J o u r n a l P r e -p r o o f the quality of evidence, version, developers, and a number of developed organizations. A total of four qualified appraisers had been trained through online practice grading and pre-grading before the formal assessment. The pre-grading was carried out by randomly selecting three eligible guidelines to ensure that each researcher had basically the same understanding of each item. The AGREE II instrument provided an objective evaluation to assess the quality of guidelines. It consists of six domains and two overall guideline assessments. Each item was scored from 1 (strongly disagree) to 7 (strongly agree). Scores were derived as the percentage of the maximal possible score for each domain, using the following specific formula: (obtained scoreminimal possible score)/(maximal possible score -minimal possible score). We assigned double weight to the domains of rigor of development and applicability. A total score greater than 60% would be determined as "recommended", score between 30% and 60% as "recommended with modification" and below 30% as "not recommended". No patients were involved. We read each guideline in detail and extracted clinical recommendations related to Additionally, the quality of Stakeholder Involvement and Applicability was also low. Because the development of a guideline required the participation of multidisciplinary experts, revealing the methodology followed was essential, but almost only the guidelines developed by international organizations met the criteria. Furthermore, the views and preferences of the target population were rarely sought. Besides, as a highly required resource, each region's ability to use NIV was distinct, which could be one reason leading to the formation of different clinical recommendations, but this explanation was reported rarely. This review emphasized the issues that should be given attention when developing guidelines for future pandemics. There is still insufficient evidence for using NIV. Therefore, it is vital to improve the methodological quality of the guidelines to make the clinical recommendations more reliable. Moreover, well-designed randomized clinical trials are needed to solve the current debate on the use of NIV. J o u r n a l P r e -p r o o f The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China Severe Covid-19 2019-nCoV) Infection: Part II-Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration Clinical care for severe acute respiratory infection: toolkit. COVID-19 adaptation THE AMERICAS Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected (ncov)-infection-is-suspected Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) Physiotherapy Management for COVID-19 in the Acute Hospital Setting:Recommendations to guide clinical practice Clinical management of patients with moderate to severe COVID-19 -Interim guidance Coronavirus Diseases 2019 (COVID-19) Treatment Guidelines Australian guidelines for the clinical care of people with COVID-19 Interim guidelines for the clinical management of COVID-19 in adults NHC&SATCM. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 1-clinical-protocols-for-the-diagnosis-and-treatment-of-covid-19-v7pdf?sfvrsn=c6cbfba4_2 Guidance for the management of adult patients with coronavirus disease 2019 PCS. COVID-19 Management Guidelines. wwwpakistanchestsocietypk Guidelines on Clinical management of severe acute respiratory illness (SARI) in suspect/confirmed novel coronavirus (nCoV) cases The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice Managing the Respiratory care of patients with COVID-19 Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management Lombardy Section of the Italian Society of Infectious and Tropical Diseases. Vademecum for the treatment of people with COVID-19 Guidance for the role and use of non-invasive respiratory support in adult patients with COVID-19 Clinical management of persons admitted to hospital with suspected COVID-19 infection Use of acute NIV in patients hospitalised with suspected or confirmed COVID-19 infection Respiratory support of patients on medical wards Guidance document for the Intensive Care Management of the adult patient with confirmed or suspected COVID-19 German recommendations for critically ill patients with COVID19 Swiss Society of Intensive Care Medicine. Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs) AGREE II-improving the quality of clinical care Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial Non-invasive ventilation with helmet in patients with respiratory failure caused by acute exacerbation of chronic obstructive pulmonary disease Noninvasive Ventilation in Acute Hypoxemic Nonhypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome Noninvasive positive-pressure ventilation for postextubation respiratory distress: a randomized controlled trial Noninvasive positive-pressure ventilation for respiratory failure after extubation Noninvasive ventilation during persistent weaning failure: a randomized controlled trial Continuous Positive Airway Pressure. StatPearls, StatPearls Publishing Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 None. J o u r n a l P r e -p r o o f None. The authors declare that they have no competing interests. The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. All authors have completed the ICMJE uniform disclosure form. The authors have no conflicts of interest to declare. None. The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.